Cargando…
Cell-type specific potent Wnt signaling blockade by bispecific antibody
Cell signaling pathways are often shared between normal and diseased cells. How to achieve cell type-specific, potent inhibition of signaling pathways is a major challenge with implications for therapeutic development. Using the Wnt/β-catenin signaling pathway as a model system, we report here a nov...
Autores principales: | Lee, Nam-Kyung, Zhang, Yafeng, Su, Yang, Bidlingmaier, Scott, Sherbenou, Daniel W., Ha, Kevin D., Liu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768681/ https://www.ncbi.nlm.nih.gov/pubmed/29335534 http://dx.doi.org/10.1038/s41598-017-17539-z |
Ejemplares similares
-
High-content Analysis of Antibody Phage-display Library Selection Outputs Identifies Tumor Selective Macropinocytosis-dependent Rapidly Internalizing Antibodies
por: Ha, Kevin D., et al.
Publicado: (2014) -
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
por: Kobold, Sebastian, et al.
Publicado: (2018) -
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
por: Dheilly, Elie, et al.
Publicado: (2018) -
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Lin, Tsung-Yi, et al.
Publicado: (2021) -
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)